Ben Veghte


WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after the House of Representatives overwhelmingly passed H.R. 6, the 21st Century Cures Act of 2015.

“Today’s passage in the House of the 21st Century Cures Act is a huge win for the U.S. medical innovation ecosystem and an example of bipartisanship at work to address some of our nation’s most pressing challenges,” said Bobby Franklin, President and CEO of NVCA.  “By increasing NIH funding and improving the environment for drug development, this bill goes a long way in ensuring the U.S. remains the global hub of medical innovation.  We congratulate Chairman Upton and Rep. DeGette for this tremendous achievement and thank them for pushing the ball forward on this important issue.”

About National Venture Capital Association

Venture capitalists are committed to funding America’s most innovative entrepreneurs, working closely with them to transform breakthrough ideas into emerging growth companies that drive U.S. job creation and economic growth. As the voice of the U.S. venture capital community, the National Venture Capital Association (NVCA) empowers its members and the entrepreneurs they fund by advocating for policies that encourage innovation and reward long-term investment. As the venture community’s preeminent trade association, NVCA serves as the definitive resource for venture capital data and unites its nearly 400 members through a full range of professional services. For more information about the NVCA, please visit